O2 and Mavenir successfully trial technology to improve call clarity for people with hearing loss
VyOS Powers UCJC’s Hands-On Routing and Cybersecurity Labs Beyond Simulators
Nissan AMIEO Completes 180-Market Pricing Transformation with Syncron, Ahead of Schedule
Pax8 and Google Announce Global Partnership to Equip MSPs and their SMB Customers with Enterprise-Grade Solutions
Timeero Launches Auto Clock-In/Out to Eliminate Missed Punches for Field Teams
The must-attend conference helps manufacturers and engineers navigate supply chain challenges and accelerate the adoption…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its Equipment Loan & Lease indices for March 2022. March remittance…
WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties, Inc. (NYSE:LTC) announced today that it had declared a monthly…
MIAMI & DALLAS–(BUSINESS WIRE)–#cordials—Southern Glazer’s Wine & Spirits (Southern Glazer’s)—the world’s preeminent distributor of beverage…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its marketplace consumer loan indices for March. March remittance reports continued…
BOSTON, April 01, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Presentations highlight potential of losmapimod to slow or stop progression of FSHD Company on track…
LAS VEGAS, April 01, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading…
ANAHEIM, CA, April 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
Two poster presentations highlight Phase 1 data for LP352 in healthy volunteers SAN DIEGO, April…
MIAMI, April 01, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative…
Results from Phase 1b/2a study of efzofitimod in pulmonary sarcoidosis patients demonstrate safety and dose…
FLORHAM PARK, N.J., April 01, 2022 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a…
NEW YORK, NY, April 01, 2022 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo”…
CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a company…
CARLSBAD, Calif., April 01, 2022 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified…
SAN FRANCISCO, April 01, 2022 (GLOBE NEWSWIRE) — Neurona Therapeutics, a clinical-stage biotherapeutics company advancing…
LAWRENCEVILLE, N.J., April 01, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused…
The Company also announces completion of enrollment in 12-week, Phase 1b trial of pemvidutide in…